Chicago, ILLINOIS4 Active Studies

Gallbladder Cancer Clinical Trials in Chicago, ILLINOIS

Find 4 actively recruiting gallbladder cancer clinical trials in Chicago, ILLINOIS. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
436
Enrolling

Recruiting Gallbladder Cancer Studies in Chicago

RecruitingChicago, ILLINOISNCT05948475

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

This study is a Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician's Choice in Subjects with Fibroblast Growth Factor...

200 participants
TransThera Sciences (Nanjing), Inc.
View Study Details
RecruitingChicago, ILLINOISNCT06777316

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

This is an open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), pharmacodynamic (what the drug does to the body), and antitumor activity o...

110 participants
Cogent Biosciences, Inc.
View Study Details
RecruitingChicago, ILLINOISNCT05874414

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

This is an open-label, multicenter Phase 1b/2a study to evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of GNS561 in combination with trametinib in Advanced KRAS Mutated Cho...

74 participants
Genfit
View Study Details
RecruitingChicago, ILLINOISNCT06501625

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

The objective of this study is to investigate the safety, tolerability and preliminary activity of ivosidenib in combination with durvalumab and gemcitabine/cisplatin as first-line therapy in particip...

52 participants
Institut de Recherches Internationales Servier
View Study Details

About Gallbladder Cancer Clinical Trials in Chicago

Gallbladder cancer and bile duct cancers (cholangiocarcinoma) are rare cancers of the biliary system. They are often diagnosed at advanced stages due to vague symptoms. Treatment includes surgery, chemotherapy, and targeted therapy based on genetic mutations.

There are currently 4 gallbladder cancer clinical trials recruiting participants in Chicago, ILLINOIS. These studies are seeking a combined 436 participants. Research is being sponsored by TransThera Sciences (Nanjing), Inc., Cogent Biosciences, Inc., Genfit and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Gallbladder Cancer Clinical Trials in Chicago — FAQ

Are there gallbladder cancer clinical trials in Chicago?

Yes, there are 4 gallbladder cancer clinical trials currently recruiting in Chicago, ILLINOIS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What gallbladder cancer treatments are being tested?

The 4 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for gallbladder cancer.

Data updated March 2, 2026 from ClinicalTrials.gov